Adaptive Biotechnologies
(NASDAQ) ADPT
Adaptive Biotechnologies Financials at a Glance
Market Cap
$2.24B
Revenue (TTM)
$276.98M
Net Income (TTM)
$59.50M
EPS (TTM)
$-0.40
P/E Ratio
-36.44
Dividend
$0.00
Beta (Volatility)
2.01 (High)
Dividend
$0.00
Beta (Volatility)
2.01 (High)
Price
$14.60
Volume
14,745
Open
$14.49
Price
$14.60
Volume
14,745
Open
$14.49
Previous Close
$14.53
Daily Range
$14.44 - $14.86
52-Week Range
$6.77 - $20.76
Dividend
$0.00
Beta (Volatility)
2.01 (High)
Price
$14.60
Volume
14,745
Open
$14.49
Previous Close
$14.53
Daily Range
$14.44 - $14.86
52-Week Range
$6.77 - $20.76
ADPT News
ADPT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Adaptive Biotechnologies
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
624
CEO
Chad Robins, MBA
Website
www.adaptivebiotech.comHeadquarters
Seattle, WA 98109, US
ADPT Financials
Key Financial Metrics (TTM)
Gross Margin
74%
Operating Margin
-21%
Net Income Margin
-21%
Return on Equity
-28%
Return on Capital
-14%
Return on Assets
-12%
Earnings Yield
-2.74%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.24B
Shares Outstanding
153.98M
Volume
14.74K
Short Interest
0.00%
Avg. Volume
2.01M
Financials (TTM)
Gross Profit
$205.62M
Operating Income
$57.12M
EBITDA
$29.85M
Operating Cash Flow
$45.99M
Capital Expenditure
$2.96M
Free Cash Flow
$48.95M
Cash & ST Invst.
$226.98M
Total Debt
$280.58M
Adaptive Biotechnologies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$71.68M
+51.0%
Gross Profit
$53.46M
+81.7%
Gross Margin
74.58%
N/A
Market Cap
$2.24B
N/A
Market Cap/Employee
$3.61M
N/A
Employees
619
N/A
Net Income
$13.58M
+59.7%
EBITDA
$6.43M
+75.6%
Quarterly Fundamentals
Net Cash
$53.60M
-140.3%
Accounts Receivable
$50.37M
+20.7%
Inventory
$9.82M
+16.4%
Long Term Debt
$267.02M
+237.4%
Short Term Debt
$13.56M
+32.5%
Return on Assets
-11.60%
N/A
Return on Invested Capital
-13.51%
N/A
Free Cash Flow
$1.42M
+111.3%
Operating Cash Flow
$2.06M
+116.5%